Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer

被引:0
|
作者
MA Dall'Era
S-J Shih
J Yang
S Benik
R Gandour-Edwards
CP Evans
机构
[1] University of California,Department of Urology
[2] Davis School of Medicine,Department of Pathology
[3] University of California,undefined
[4] Davis School of Medicine,undefined
关键词
basic fibroblast growth factor; vascular endothelial growth factor; tumor necrosis factor alpha; urokinase; primary prostate culture;
D O I
暂无
中图分类号
学科分类号
摘要
Studies on angiogenic cytokines usually are initially based upon their expression by available established cell lines. Our hypothesis is that established epithelial prostate cancer (CaP) cell lines do not accurately reflect angiogenic cytokine expression as compared to epithelial and stromal components of primary cultures generated from clinical CaP specimens. Serum free and growth factor free conditioned medium (CM) was collected from PC3, LNCaP, and their orthotopic selected prostate cancer sublines. Surgically acquired and pathologically confirmed neoplastic prostate tissue was selectively grown for selection of epithelial or stromal components, and CM was also collected. CM was assayed for urokinase (u-PA), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and tumor necrosis factor alpha (TNF-α). u-PA was expressed only by androgen independent cell lines, but was detectable in the epithelial and stromal cultures of androgen sensitive primary cultures. bFGF was not secreted by cell lines nor epithelial primary cultures. VEGF was universally expressed, but TNF-α was not secreted by cells lines nor primary cultures. These data suggest that the expression of angiogenic cytokines by established epithelial CaP cell lines does not reflect epithelial and stromal primary cultures.
引用
收藏
页码:106 / 111
页数:5
相关论文
共 50 条
  • [31] Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines
    Shaikhibrahim, Zaki
    Lindstrot, Andreas
    Langer, Berit
    Buettner, Reinhard
    Wernert, Nicolas
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (01) : 89 - 93
  • [32] Hormonal ablation in primary prostate cancer cultures -: Effects on cell growth and gene expression.
    Buehler, Patrick
    Freudenberg, Nikolaus
    Katzenwadel, Arndt
    Schultze-Seemann, Wolfgang
    Wetterauer, Ulrich
    Elsaesser-Beile, Ursula
    TUMOR BIOLOGY, 2006, 27
  • [33] THROMBOPOIETIN RECEPTOR EXPRESSION IN HUMAN CANCER CELL-LINES AND PRIMARY TISSUES
    COLUMBYOVA, L
    LODA, M
    SCADDEN, DT
    CANCER RESEARCH, 1995, 55 (16) : 3509 - 3512
  • [34] Analyzing the Expression of Biomarkers in Prostate Cancer Cell Lines
    Su, Chen-Ying
    Huang, Gwo-Che
    Chang, You-Cheng
    Chen, Yu-Jen
    Fang, Hsu-Wei
    IN VIVO, 2021, 35 (03): : 1545 - 1548
  • [35] Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines
    Dovio, Andrea
    Sartori, Maria Luisa
    De Francia, Silvia
    Mussino, Stefano
    Perotti, Paola
    Saba, Laura
    Abbadessa, Giuliana
    Racca, Silvia
    Angeli, Alberto
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 116 (1-2): : 29 - 36
  • [36] Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines
    Usmani, BA
    Harden, B
    Maitland, NJ
    Turner, AJ
    CLINICAL SCIENCE, 2002, 103 : 314S - 317S
  • [37] Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
    W Zoli
    L Ricotti
    M Dal Susino
    F Barzanti
    G L Frassineti
    S Folli
    A Tesei
    F Bacci
    D Amadori
    British Journal of Cancer, 1999, 81 : 609 - 615
  • [38] Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
    Zoli, W
    Ricotti, L
    Dal Susino, N
    Barzanti, F
    Frassineti, GL
    Folli, S
    Tesei, A
    Bacci, F
    Amadori, D
    BRITISH JOURNAL OF CANCER, 1999, 81 (04) : 609 - 615
  • [39] Bicalutamide Demonstrates Biologic Effectiveness in Prostate Cancer Cell Lines and Tumor Primary Cultures Irrespective of Her2/neu Expression Levels
    Gravina, Giovanni Luca
    Festuccia, Claudio
    Millimaggi, Danilo
    Tornbolini, Vincenzo
    Dolo, Vincenza
    Vicentini, Carlo
    Bologna, Mauro
    UROLOGY, 2009, 74 (02) : 452 - 457
  • [40] Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors
    Han, EKH
    Lim, JTE
    Arber, N
    Rubin, MA
    Xing, WQ
    Weinstein, IB
    PROSTATE, 1998, 35 (02): : 95 - 101